July 23, 2026

Impact of Overweight on Cancer Risk May Be Significantly Underestimated

Impact of Overweight on Cancer Risk May Be Significantly Underestimated

Being overweight and obesity may contribute to significantly more cancer cases than previously thought. This is the conclusion reached by researchers at the German Cancer Research Center (DKFZ). Their analysis shows that when more accurate measures of body fat and methodological biases are considered, more than 10 percent of all cancer cases can be attributed to increased body weight – nearly twice as many as previous estimates suggested.

Overweight and, in particular, obesity are known cancer risk factors. Previous studies have estimated that they account for about two to eight percent of all cancer cases. However, Hermann Brenner, an epidemiologist at the DKFZ, has long suspected that this risk proportion may have been underestimated due to methodological biases. Together with his team, he therefore analyzed data from 458,543 women and men stored in the UK Biobank to investigate the links between being overweight and cancer.

The participants were followed for a median of nearly twelve years. During this period, more than 50,000 new cancer cases occurred.

Weight and height alone are not enough

Most studies on obesity and cancer have relied on the body mass index (BMI), which is calculated from weight and height. However, BMI does not distinguish between fat and muscle mass and provides no information about where fat accumulates in the body. Yet abdominal fat, in particular, is considered to be especially metabolically active and is closely linked to inflammatory processes and other mechanisms that can promote cancer.

The DKFZ researchers therefore compared not only BMI but also waist circumference and the waist-to-hip ratio as measures of fat distribution. These parameters proved to be significantly more informative regarding cancer risk.

Methodological Bias: Cancer Often Leads to Weight Loss Even Before Diagnosis

In their current study, Brenner and his team also addressed a previously underestimated methodological issue: Many tumors cause unintentional weight loss years before they are diagnosed. As a result, patients appear slimmer at the time of their actual diagnosis, which weakens the statistical link between obesity and cancer.

To avoid potential biases caused by weight loss prior to diagnosis, the researchers gradually excluded the first few years following the participants’ enrollment in the study. This actually made the association much clearer. The explanation: A significant proportion of the cancers diagnosed during the first few years of follow-up were likely already present at the start of the study and had already led to weight loss in those affected.

More than 10 percent of all cancer cases could be preventable

In summary, the new analyses yielded significantly higher figures for the proportion of all cancer cases attributable to obesity. Taking into account all methodological improvements in the analyses, the estimated proportion of cancer cases caused by excess weight rose from about 5.5 percent to as high as 11.5 percent. This means that more than one in ten cancer cases could be linked to excess body fat.

Women appear to be more affected

The analyses also suggest that the proportion of cancer cases caused by obesity may be higher among women than among men. Body fat may also tend to play a greater role among younger adults under the age of 60.

According to Hermann Brenner, the results underscore the urgency of taking decisive action to counter the global rise in obesity. “Since the prevalence of obesity continues to rise in most countries and the population is aging at the same time, the number of cancer cases caused by obesity is likely to continue to rise significantly in the future. Effective strategies for the prevention and treatment of obesity could therefore make a much greater contribution to cancer prevention than previously assumed,” says Brenner, summarizing the significance of the new findings.

Publication:
Luna Kiran Adhikari; Fatemeh Safizadeh; Marko Mandic; Hermann Brenner: Excess Weight May Account for More than Ten Percent of all Cancers: The Underestimated Impact of the Obesity Epidemic.
Cancer Communications 2026, DOI: 10.34133/cancomm.0040

Our latest News

discover more
PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

PRAME-specific T-cell therapy in an adolescent with metastatic kidney tumor

Researchers and physicians at the Hopp Children’s Cancer Center Heidelberg (KiTZ) and other leading cancer centers report an exceptional treatment success in an adolescent with an advanced, therapy-resistant kidney tumor. Using a novel, personalized T-cell therapy, they succeeded in completely pushing back the tumor disease despite multiple metastases. The individual compassionate-use treatment has now been […]

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

Ascendis to Report Second Quarter 2026 Financial Results and Provide Business Update on August 13, 2026

COPENHAGEN, Denmark, Aug. 06, 2026 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND) today announced it plans to report second quarter 2026 financial results and provide a business update on Thursday, August 13, 2026, before the open of the U.S. financial markets. Ascendis Pharma also plans to host a conference call and live webcast on August 13, 2026, at 8:00 a.m. Eastern Time (ET) to discuss […]

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Can Protein Building Blocks Protect Against Vascular and Kidney Damage?

Researchers from the Medical Faculty Heidelberg, the Medical Faculty Mannheim, and the Centre for Organismal Studies (COS) at Heidelberg University have launched a new research project investigating so-called dipeptides. Some of these naturally occurring protein building blocks are able to neutralize toxic metabolic by-products and may therefore help protect against vascular and kidney damage, particularly […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp